secwatch.observer — SEC 8-K summary
======================================

Issuer:     Vaxart, Inc. (VXRT)
CIK:        0000072444
Form:       8-K
Filed at:   2024-03-06T23:59:59+00:00
Accession:  0001437749-24-006743
Event type: leadership
Sentiment:  neutral
Materiality: 0.75
Item codes: 5.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Vaxart appoints Steven Lo as CEO and President; Finney remains Chair
--------------------------------------------------------------------

- Steven Lo appointed CEO, President, and director effective March 18, 2024.
- Michael Finney steps down as interim CEO but continues as Board Chair.
- Lo receives base salary of $600,000/year and target bonus of 50% of salary.
- Equity awards: option for 1,000,000 shares (4-year vest) and RSU for 250,000 shares (4-year vest).
- Lo brings 25+ years biopharma experience, most recently CEO at Valitor.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/72444/000143774924006743/0001437749-24-006743-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/72444/000143774924006743/vxrt20240305c_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-24-006743

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer